Methods for managing excessive inflammatory response, which is the leading cause of severe COVID-19, are very limited and less effective (96): For example, heparin is widely used to prevent blood clots, and some immunosuppressants such as dexamethasone, IL-6 monoclonal antibodies and JAK kinase family inhibitors are used to inhibit inflammation (12–15, 97–99). This evidence concerns the gene IL6 and COVID-19.